132 related articles for article (PubMed ID: 15382063)
1. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.
Chen G; Burger MM
Int J Cancer; 2004 Nov; 112(3):393-8. PubMed ID: 15382063
[TBL] [Abstract][Full Text] [Related]
2. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.
Jesionek-Kupnicka D; Tenderenda M; Rutkowski P
J Exp Clin Cancer Res; 2002 Sep; 21(3):371-5. PubMed ID: 12385580
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
Ishii HH; Gobé GC; Pan W; Yoneyama J; Ebihara Y
J Gastroenterol Hepatol; 2002 Sep; 17(9):966-72. PubMed ID: 12167117
[TBL] [Abstract][Full Text] [Related]
5. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma.
Ikeda M; Shomori K; Endo K; Makino T; Matsuura T; Ito H
Virchows Arch; 1998 Jan; 432(1):43-7. PubMed ID: 9463586
[TBL] [Abstract][Full Text] [Related]
6. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
[TBL] [Abstract][Full Text] [Related]
8. p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus.
Chen G; Burger MM
Int J Cancer; 1999 Apr; 84(2):95-100. PubMed ID: 10096238
[TBL] [Abstract][Full Text] [Related]
9. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
10. Tubular adenoma and intramucosal intestinal-type adenocarcinoma of the stomach: what are the pathobiological differences?
Kase S; Osaki M; Honjo S; Adachi H; Ito H
Gastric Cancer; 2003; 6(2):71-9. PubMed ID: 12861397
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
12. Correlation between spontaneous apoptosis and the expression of angiogenic factors in advanced gastric adenocarcinoma.
Ikeguchi M; Cai J; Fukuda K; Oka S; Katano K; Tsujitani S; Maeta M; Kaibara N
J Exp Clin Cancer Res; 2001 Jun; 20(2):257-63. PubMed ID: 11484984
[TBL] [Abstract][Full Text] [Related]
13. Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma.
Yao XQ; Liu FK; Li JS; Qi XP; Wu B; Yin HL; Ma HH; Shi QL; Zhou XJ
World J Gastroenterol; 2004 May; 10(9):1262-7. PubMed ID: 15112339
[TBL] [Abstract][Full Text] [Related]
14. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
Ishii HH; Gobe GC; Ebihara Y
Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
[TBL] [Abstract][Full Text] [Related]
15. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
16. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
[TBL] [Abstract][Full Text] [Related]
20. Expression of p150 in cervical neoplasia and its potential value in predicting survival.
Dellas A; Torhorst J; Bachmann F; Bänziger R; Schultheiss E; Burger MM
Cancer; 1998 Oct; 83(7):1376-83. PubMed ID: 9762939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
